# Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF

> **NCT03920618** · NA · RECRUITING · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 150 (estimated)

## Conditions studied

- Hepatitis B
- Acute-On-Chronic Liver Failure

## Interventions

- **DRUG:** Entecavir
- **DRUG:** Tenofovir Disoproxil Fumarate
- **DRUG:** Tenofovir Alafenamide

## Key facts

- **NCT ID:** NCT03920618
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-02-21
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03920618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03920618, "Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03920618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*